Effect of Helicobacter pylori infection and its eradication on gastric regenerating atypia in 22 133 subjects

Background and Aim The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion. Methods In cross‐sectional setting, comprehensive health check‐up subjects who underwent both en...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastroenterology and hepatology Vol. 35; no. 9; pp. 1532 - 1539
Main Authors Nam, Ji Hyung, Nam, Su Youn, Park, Bum Joon, Ryu, Kum Hei
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.09.2020
Subjects
Online AccessGet full text
ISSN0815-9319
1440-1746
1440-1746
DOI10.1111/jgh.15016

Cover

Loading…
Abstract Background and Aim The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion. Methods In cross‐sectional setting, comprehensive health check‐up subjects who underwent both endoscopy and H. pylori test from 2001 to 2009 were included. The association between H. pylori and gastric regenerating atypia was evaluated. In cohort setting, patients with regenerating atypia who underwent H. pylori test from 2001 to 2013 were included. Factors affecting positive pathology (persistent regenerating atypia or new development of neoplasm) in patients with regenerating atypia at baseline were investigated. Results In cross‐sectional setting, regenerating atypia was observed in 1.1% (241/22 133). H. pylori infection was associated with gastric regenerating atypia (adjusted odds ratio, 1.47; 95% confidence interval [CI], 1.12–1.91). In cohort setting, 310 patients with regenerating atypia were finally eligible. Positive pathology rate during follow up was 16.1% (15/93) in the persistent infection group, 2.8% (3/106) in successful eradication group, and 4.5% (5/111) in baseline H. pylori‐negative group. Persistent H. pylori infection increased the risk of positive pathology (adjusted risk ratio [RR], 7.18; 95% CI, 1.95–26.48) compared to H. pylori eradication group. Persistent H. pylori infection increased the risk of regenerative atypia (adjusted RR, 5.70; 95% CI, 1.46–22.17) and new neoplasm (adjusted RR, 10.74; 95% CI, 1.10–105.17) compared to baseline negative H. pylori. Conclusions H. pylori infection is an independent risk factor for gastric regenerating atypia. Eradication of H. pylori seems helpful for regression of regenerating atypia.
AbstractList Background and AimThe aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion.MethodsIn cross‐sectional setting, comprehensive health check‐up subjects who underwent both endoscopy and H. pylori test from 2001 to 2009 were included. The association between H. pylori and gastric regenerating atypia was evaluated. In cohort setting, patients with regenerating atypia who underwent H. pylori test from 2001 to 2013 were included. Factors affecting positive pathology (persistent regenerating atypia or new development of neoplasm) in patients with regenerating atypia at baseline were investigated.ResultsIn cross‐sectional setting, regenerating atypia was observed in 1.1% (241/22 133). H. pylori infection was associated with gastric regenerating atypia (adjusted odds ratio, 1.47; 95% confidence interval [CI], 1.12–1.91). In cohort setting, 310 patients with regenerating atypia were finally eligible. Positive pathology rate during follow up was 16.1% (15/93) in the persistent infection group, 2.8% (3/106) in successful eradication group, and 4.5% (5/111) in baseline H. pylori‐negative group. Persistent H. pylori infection increased the risk of positive pathology (adjusted risk ratio [RR], 7.18; 95% CI, 1.95–26.48) compared to H. pylori eradication group. Persistent H. pylori infection increased the risk of regenerative atypia (adjusted RR, 5.70; 95% CI, 1.46–22.17) and new neoplasm (adjusted RR, 10.74; 95% CI, 1.10–105.17) compared to baseline negative H. pylori.ConclusionsH. pylori infection is an independent risk factor for gastric regenerating atypia. Eradication of H. pylori seems helpful for regression of regenerating atypia.
The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion. In cross-sectional setting, comprehensive health check-up subjects who underwent both endoscopy and H. pylori test from 2001 to 2009 were included. The association between H. pylori and gastric regenerating atypia was evaluated. In cohort setting, patients with regenerating atypia who underwent H. pylori test from 2001 to 2013 were included. Factors affecting positive pathology (persistent regenerating atypia or new development of neoplasm) in patients with regenerating atypia at baseline were investigated. In cross-sectional setting, regenerating atypia was observed in 1.1% (241/22 133). H. pylori infection was associated with gastric regenerating atypia (adjusted odds ratio, 1.47; 95% confidence interval [CI], 1.12-1.91). In cohort setting, 310 patients with regenerating atypia were finally eligible. Positive pathology rate during follow up was 16.1% (15/93) in the persistent infection group, 2.8% (3/106) in successful eradication group, and 4.5% (5/111) in baseline H. pylori-negative group. Persistent H. pylori infection increased the risk of positive pathology (adjusted risk ratio [RR], 7.18; 95% CI, 1.95-26.48) compared to H. pylori eradication group. Persistent H. pylori infection increased the risk of regenerative atypia (adjusted RR, 5.70; 95% CI, 1.46-22.17) and new neoplasm (adjusted RR, 10.74; 95% CI, 1.10-105.17) compared to baseline negative H. pylori. H. pylori infection is an independent risk factor for gastric regenerating atypia. Eradication of H. pylori seems helpful for regression of regenerating atypia.
Background and Aim The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion. Methods In cross‐sectional setting, comprehensive health check‐up subjects who underwent both endoscopy and H. pylori test from 2001 to 2009 were included. The association between H. pylori and gastric regenerating atypia was evaluated. In cohort setting, patients with regenerating atypia who underwent H. pylori test from 2001 to 2013 were included. Factors affecting positive pathology (persistent regenerating atypia or new development of neoplasm) in patients with regenerating atypia at baseline were investigated. Results In cross‐sectional setting, regenerating atypia was observed in 1.1% (241/22 133). H. pylori infection was associated with gastric regenerating atypia (adjusted odds ratio, 1.47; 95% confidence interval [CI], 1.12–1.91). In cohort setting, 310 patients with regenerating atypia were finally eligible. Positive pathology rate during follow up was 16.1% (15/93) in the persistent infection group, 2.8% (3/106) in successful eradication group, and 4.5% (5/111) in baseline H. pylori‐negative group. Persistent H. pylori infection increased the risk of positive pathology (adjusted risk ratio [RR], 7.18; 95% CI, 1.95–26.48) compared to H. pylori eradication group. Persistent H. pylori infection increased the risk of regenerative atypia (adjusted RR, 5.70; 95% CI, 1.46–22.17) and new neoplasm (adjusted RR, 10.74; 95% CI, 1.10–105.17) compared to baseline negative H. pylori. Conclusions H. pylori infection is an independent risk factor for gastric regenerating atypia. Eradication of H. pylori seems helpful for regression of regenerating atypia.
The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion.BACKGROUND AND AIMThe aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on the course of this lesion.In cross-sectional setting, comprehensive health check-up subjects who underwent both endoscopy and H. pylori test from 2001 to 2009 were included. The association between H. pylori and gastric regenerating atypia was evaluated. In cohort setting, patients with regenerating atypia who underwent H. pylori test from 2001 to 2013 were included. Factors affecting positive pathology (persistent regenerating atypia or new development of neoplasm) in patients with regenerating atypia at baseline were investigated.METHODSIn cross-sectional setting, comprehensive health check-up subjects who underwent both endoscopy and H. pylori test from 2001 to 2009 were included. The association between H. pylori and gastric regenerating atypia was evaluated. In cohort setting, patients with regenerating atypia who underwent H. pylori test from 2001 to 2013 were included. Factors affecting positive pathology (persistent regenerating atypia or new development of neoplasm) in patients with regenerating atypia at baseline were investigated.In cross-sectional setting, regenerating atypia was observed in 1.1% (241/22 133). H. pylori infection was associated with gastric regenerating atypia (adjusted odds ratio, 1.47; 95% confidence interval [CI], 1.12-1.91). In cohort setting, 310 patients with regenerating atypia were finally eligible. Positive pathology rate during follow up was 16.1% (15/93) in the persistent infection group, 2.8% (3/106) in successful eradication group, and 4.5% (5/111) in baseline H. pylori-negative group. Persistent H. pylori infection increased the risk of positive pathology (adjusted risk ratio [RR], 7.18; 95% CI, 1.95-26.48) compared to H. pylori eradication group. Persistent H. pylori infection increased the risk of regenerative atypia (adjusted RR, 5.70; 95% CI, 1.46-22.17) and new neoplasm (adjusted RR, 10.74; 95% CI, 1.10-105.17) compared to baseline negative H. pylori.RESULTSIn cross-sectional setting, regenerating atypia was observed in 1.1% (241/22 133). H. pylori infection was associated with gastric regenerating atypia (adjusted odds ratio, 1.47; 95% confidence interval [CI], 1.12-1.91). In cohort setting, 310 patients with regenerating atypia were finally eligible. Positive pathology rate during follow up was 16.1% (15/93) in the persistent infection group, 2.8% (3/106) in successful eradication group, and 4.5% (5/111) in baseline H. pylori-negative group. Persistent H. pylori infection increased the risk of positive pathology (adjusted risk ratio [RR], 7.18; 95% CI, 1.95-26.48) compared to H. pylori eradication group. Persistent H. pylori infection increased the risk of regenerative atypia (adjusted RR, 5.70; 95% CI, 1.46-22.17) and new neoplasm (adjusted RR, 10.74; 95% CI, 1.10-105.17) compared to baseline negative H. pylori.H. pylori infection is an independent risk factor for gastric regenerating atypia. Eradication of H. pylori seems helpful for regression of regenerating atypia.CONCLUSIONSH. pylori infection is an independent risk factor for gastric regenerating atypia. Eradication of H. pylori seems helpful for regression of regenerating atypia.
Author Nam, Su Youn
Park, Bum Joon
Nam, Ji Hyung
Ryu, Kum Hei
Author_xml – sequence: 1
  givenname: Ji Hyung
  orcidid: 0000-0002-7083-7581
  surname: Nam
  fullname: Nam, Ji Hyung
  organization: Dongguk University Ilsan Hospital, Dongguk University College of Medicine
– sequence: 2
  givenname: Su Youn
  orcidid: 0000-0002-5568-7714
  surname: Nam
  fullname: Nam, Su Youn
  email: nam20131114@gmail.com
  organization: Kyungpook National University
– sequence: 3
  givenname: Bum Joon
  surname: Park
  fullname: Park, Bum Joon
  organization: National Cancer Center
– sequence: 4
  givenname: Kum Hei
  surname: Ryu
  fullname: Ryu, Kum Hei
  organization: National Cancer Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32083327$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1q3DAUhUVJaSZpF32BIuimXTi5-rFsL0tIMwmBbNK1kOXrqQaPNJVkwrxNn6VPVmUmzSKQCoFA5ztH4p4TcuSDR0I-MjhjZZ2vVz_PWA1MvSELJiVUrJHqiCygZXXVCdYdk5OU1gAgoanfkWPBoRWCNwviL8cRbaZhpEucnA29sRkj3e6mEB11_lF1wVPjB-pyohjN4KzZ35W9MilHZ2nEFfqiZedX1OTd1plippz_-c2EoGnu1yUovSdvRzMl_PB0npIf3y_vL5bV7d3V9cW328py1aoKoeEAXd0NspdDbwzUclRitICKN8gtGyWg6LpBoeyZ6rsBimZssfFBcXFKvhxytzH8mjFlvXHJ4jQZj2FOmouGtbUojxX08wt0Heboy-80l1I0vK7brlCfnqi53-Cgt9FtTNzpf5MswNcDYGNIKeL4jDDQjy3p0pLet1TY8xesdXk_0hyNm_7neHAT7l6P1jdXy4PjL2FhomE
CitedBy_id crossref_primary_10_7704_kjhugr_2023_0014
Cites_doi 10.1136/gut.51.1.130
10.3109/00365521.2012.704939
10.1111/j.0083-8703.2006.00373.x
10.1002/1097-0142(19841101)54:9<1794::AID-CNCR2820540907>3.0.CO;2-W
10.1016/j.dld.2013.01.015
10.1093/gastro/gou093
10.1097/00000478-200002000-00001
10.1046/j.1365-2036.2001.00110.x
10.1007/s10620-014-3249-5
10.1097/PAT.0b013e32835f21d7
10.1007/s10620-012-2427-6
10.3748/wjg.v20.i28.9621
10.1007/s10120-011-0041-5
10.1136/gut.47.2.251
10.1016/S0928-4257(01)00048-1
ContentType Journal Article
Copyright 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd
2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Copyright_xml – notice: 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd
– notice: 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
DBID AAYXX
CITATION
NPM
7T5
7U9
H94
K9.
7X8
DOI 10.1111/jgh.15016
DatabaseName CrossRef
PubMed
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1440-1746
EndPage 1539
ExternalDocumentID 32083327
10_1111_jgh_15016
JGH15016
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
DU5
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7T5
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c2686-e07200959d4b4dbaa054f63fc0e627e2c1f40e399d6e4b16b9d0c0eac7202d623
IEDL.DBID DR2
ISSN 0815-9319
1440-1746
IngestDate Fri Jul 11 04:26:53 EDT 2025
Wed Aug 13 08:31:10 EDT 2025
Wed Feb 19 02:31:04 EST 2025
Thu Apr 24 23:11:32 EDT 2025
Tue Jul 01 01:45:21 EDT 2025
Wed Jan 22 16:32:40 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords regenerating atypia
Helicobacter pylori
H. pylori eradication
Language English
License 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2686-e07200959d4b4dbaa054f63fc0e627e2c1f40e399d6e4b16b9d0c0eac7202d623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5568-7714
0000-0002-7083-7581
PMID 32083327
PQID 2443725589
PQPubID 2045136
PageCount 8
ParticipantIDs proquest_miscellaneous_2371853268
proquest_journals_2443725589
pubmed_primary_32083327
crossref_primary_10_1111_jgh_15016
crossref_citationtrail_10_1111_jgh_15016
wiley_primary_10_1111_jgh_15016_JGH15016
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2020
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: September 2020
PublicationDecade 2020
PublicationPlace Australia
PublicationPlace_xml – name: Australia
– name: Richmond
PublicationTitle Journal of gastroenterology and hepatology
PublicationTitleAlternate J Gastroenterol Hepatol
PublicationYear 2020
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2013; 58
2015; 3
2000; 47
2000; 24
2002; 51
2006; 11
2013; 45
1984; 54
2014; 59
1999; 34
2001; 15
2011; 14
2012; 47
2015; 9
2001; 95
2014; 20
Gotoda T (e_1_2_6_18_1) 1999; 34
e_1_2_6_10_1
Mujawar P (e_1_2_6_8_1) 2015; 9
e_1_2_6_9_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 47
  start-page: 1101
  year: 2012
  end-page: 1107
  article-title: The diagnostic role of endoscopic submucosal dissection for gastric lesions with indefinite pathology
  publication-title: Scand. J. Gastroenterol.
– volume: 3
  start-page: 238
  year: 2015
  end-page: 242
  article-title: Histopathological study using computer database of 10 000 consecutive gastric specimens: (1) benign conditions
  publication-title: Gastroenterol. Rep. (Oxf.)
– volume: 45
  start-page: 573
  year: 2013
  end-page: 577
  article-title: What is the next step for gastric atypical epithelium on histological findings of endoscopic forceps biopsy?
  publication-title: Dig. Liver Dis.
– volume: 15
  start-page: 43
  year: 2001
  end-page: 50
  article-title: Review article: pre‐neoplastic states of the gastric mucosa—a practical approach for the perplexed clinician
  publication-title: Aliment. Pharmacol. Ther.
– volume: 11
  start-page: 10
  year: 2006
  end-page: 20
  article-title: Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)‐2 expression, apoptosis, and functional gastric mucosal impairment in ‐infected Mongolian gerbils
  publication-title: Helicobacter
– volume: 47
  start-page: 251
  year: 2000
  end-page: 255
  article-title: The Vienna classification of gastrointestinal epithelial neoplasia
  publication-title: Gut
– volume: 9
  start-page: EC04
  year: 2015
  end-page: EC06
  article-title: associated gastritis in northern Maharashtra, India: a histopathological study of gastric mucosal biopsies
  publication-title: J. Clin. Diagn. Res.
– volume: 51
  start-page: 130
  year: 2002
  end-page: 131
  article-title: Gastrointestinal epithelial neoplasia: Vienna revisited
  publication-title: Gut
– volume: 45
  start-page: 273
  year: 2013
  end-page: 285
  article-title: Gastrointestinal dysplasia
  publication-title: Pathology
– volume: 34
  start-page: 91
  year: 1999
  end-page: 96
  article-title: Endoscopic and histological reversibility of gastric adenoma after eradication of
  publication-title: J. Gastroenterol.
– volume: 54
  start-page: 1794
  year: 1984
  end-page: 1801
  article-title: Gastric dysplasia. Significance and pathologic criteria
  publication-title: Cancer
– volume: 24
  start-page: 167
  year: 2000
  end-page: 176
  article-title: Gastric dysplasia: the Padova international classification
  publication-title: Am. J. Surg. Pathol.
– volume: 14
  start-page: 101
  year: 2011
  end-page: 112
  article-title: Japanese classification of gastric carcinoma: 3rd English edition
  publication-title: Gastric Cancer
– volume: 59
  start-page: 3012
  year: 2014
  end-page: 3020
  article-title: Endoscopic resection as a first therapy for gastric epithelial atypia: is it reasonable?
  publication-title: Dig. Dis. Sci.
– volume: 95
  start-page: 355
  year: 2001
  end-page: 360
  article-title: Effect of infection and eradication on gastric epithelial cell proliferation and apoptosis
  publication-title: J. Physiol. Paris
– volume: 20
  start-page: 9621
  year: 2014
  end-page: 9625
  article-title: Undiagnosed Borrmann type II gastric cancer due to necrosis and regenerative epithelium
  publication-title: World J. Gastroenterol.
– volume: 58
  start-page: 634
  year: 2013
  end-page: 640
  article-title: High expression of gastrin receptor protein in injured mucosa of ‐positive gastritis
  publication-title: Dig. Dis. Sci.
– ident: e_1_2_6_5_1
  doi: 10.1136/gut.51.1.130
– ident: e_1_2_6_13_1
  doi: 10.3109/00365521.2012.704939
– ident: e_1_2_6_6_1
  doi: 10.1111/j.0083-8703.2006.00373.x
– ident: e_1_2_6_10_1
  doi: 10.1002/1097-0142(19841101)54:9<1794::AID-CNCR2820540907>3.0.CO;2-W
– ident: e_1_2_6_14_1
  doi: 10.1016/j.dld.2013.01.015
– ident: e_1_2_6_11_1
  doi: 10.1093/gastro/gou093
– ident: e_1_2_6_2_1
  doi: 10.1097/00000478-200002000-00001
– ident: e_1_2_6_7_1
  doi: 10.1046/j.1365-2036.2001.00110.x
– ident: e_1_2_6_12_1
  doi: 10.1007/s10620-014-3249-5
– ident: e_1_2_6_16_1
  doi: 10.1097/PAT.0b013e32835f21d7
– volume: 34
  start-page: 91
  year: 1999
  ident: e_1_2_6_18_1
  article-title: Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori
  publication-title: J. Gastroenterol.
– ident: e_1_2_6_9_1
  doi: 10.1007/s10620-012-2427-6
– ident: e_1_2_6_15_1
  doi: 10.3748/wjg.v20.i28.9621
– volume: 9
  start-page: EC04
  year: 2015
  ident: e_1_2_6_8_1
  article-title: Helicobacter pylori associated gastritis in northern Maharashtra, India: a histopathological study of gastric mucosal biopsies
  publication-title: J. Clin. Diagn. Res.
– ident: e_1_2_6_3_1
  doi: 10.1007/s10120-011-0041-5
– ident: e_1_2_6_4_1
  doi: 10.1136/gut.47.2.251
– ident: e_1_2_6_17_1
  doi: 10.1016/S0928-4257(01)00048-1
SSID ssj0004075
Score 2.3013034
Snippet Background and Aim The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter...
The aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter pylori eradication on...
Background and AimThe aim of this study was to identify factors affecting persistent gastric regenerating atypia and determine the effect of Helicobacter...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1532
SubjectTerms Endoscopy
Eradication
H. pylori eradication
Helicobacter pylori
Infections
Pathology
Persistent infection
regenerating atypia
Risk factors
Tumors
Title Effect of Helicobacter pylori infection and its eradication on gastric regenerating atypia in 22 133 subjects
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.15016
https://www.ncbi.nlm.nih.gov/pubmed/32083327
https://www.proquest.com/docview/2443725589
https://www.proquest.com/docview/2371853268
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB7Eg3jx_VhfRPHgpUubpu0WTyLqIuhBXPAglLy6Lkp32XYP-mv8Lf4yJ-lD1weI0EMhE5I0M5lvkukXgENEsGEYcO1w1mEO4zF1hIqkw1QnEJ5MhZdats_rsNtjl3fB3Qwc1__ClPwQzYabsQy7XhsD5yL_bOT9hzaiGc_QbZtcLQOIbj6oo1hJsoseL3Bi1LOKVchm8dQ1p33RN4A5jVetwzlfhPu6q2WeyWN7Uoi2fPnC4vjPsSzBQgVEyUmpOcswo7MVmLuqjtpXISt5jckwJeiaUF-E5XUmIxPhD0idxJURnikyKHKix1xVG4AEnz43N4JIMtZ9y2xt0qsJL55HA46VCaVvrxi4knwizE5Qvga987Pb065TXc7gSIrz62g3opbWWDHBlOAcsV8a-ql0dUgjTaWXMlcj_FGhZsILRaxcLOMSq1GFoGsdZrNhpjeBqDRIdRCICB0niyUXisdMdwLlSZfjitOCo3qaElkxl5sLNJ6SJoLpPyT2-7XgoBEdlXQdPwnt1HOdVBabJwhz_Ajjq07cgv2mGG3NHKDwTA8nKONHBt7g-FuwUepI04pPEcz6NMLO2pn-vfnk8qJrX7b-LroN89QE-ja5bQdmi_FE7yIaKsSeVft34UkFdg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB4BKwGXffEqy4JBHLikShwnaSQuCC1bWNoDaiUuKPIrbQVKqzY97P6a_S38MsbOg2UBCSHlEMm2bMcznm_syTcAh4hgwzDg2uGsxRzGY-oIFUmHqVYgPJkKL7Vsn92w3WcX18H1AhxX_8IU_BD1gZvRDLtfGwU3B9L_avlg2EQ444WL8MFk9LYO1dUjeRQraHbR5gVOjJJW8grZOJ6q6VNr9AxiPkWs1uScfYKbarBFpMltc56LpvzzH4_je2fzGT6WWJScFMLzBRZ09hWWO-Vt-xpkBbUxGacErROKjLDUzmRinPwRqeK4MsIzRUb5jOgpV-UZIMFnwE1SEEmmemDJrU2ENeH578mIY2NC6f1f9F3JbC7MYdBsHfpnP3qnbafMz-BIikvsaDeiltlYMcGU4BzhXxr6qXR1SCNNpZcyVyMCUqFmwgtFrFws4xKbUYW4awOWsnGmt4CoNEh1EIgIbSeLJReKx0y3AuVJl-Om04Cjap0SWZKXmxwad0ntxAyGif1-DTioq04Kxo6XKu1Ui52USjtLEOn4EbpYrbgB-3Uxqpu5Q-GZHs-xjh8ZhIPzb8BmISR1Lz5FPOvTCAdrl_r17pOLn237sv32qnuw0u51LpPL8-6vb7BKjd9vY912YCmfzvV3BEe52LU68AArygmR
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkFAvvPraQsGtOPSSVeI4TiJOqHTZQouqqkgcKkV-Liuq7Go3e6C_pr-FX8bYebTQIlWVcojksWzHM55v7MlngH1EsJwnwgSCZSxgIqeB1KkKmM4SGSkrI-vZPs_48JydXCQXS3DQ_gtT80N0G27OMvx67Qx8qu3vRj667COaifgjWGE8zJxKH335xR3FapZddHlJkKOiNbRCPo2nrXrXGf2BMO8CVu9xBuvwre1rnWhy1V9Usq9-3KNx_M_BbMBag0TJYa06m7Bkyi1Y_dSctT-BsiY2JhNL0DehwkhP7EymLsQfkzaLqySi1GRczYmZCd3sABJ8RsJdCaLIzIw8tbXLryaiup6OBVYmlN78xMiVzBfSbQXNn8L54P3Xd8OguZ0hUBQnODBhSj2vsWaSaSkEgj_LY6tCw2lqqIosCw3iH80NkxGXuQ6xTCisRjWirmewXE5K8wKItok1SSJT9JwsV0JqkTOTJTpSocAlpwdv22kqVENd7m7Q-F50IczosvDfrwdvOtFpzdfxN6Gddq6LxmTnBeKcOMUAK8t78LorRmNzJyiiNJMFysSpwzc4_h48r3WkayWmiGZjmmJn_Uw_3Hxxcjz0Ly__XXQPVj8fDYqPH85Ot-ExdUG_T3TbgeVqtjCvEBlVctdbwC0nZAhJ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Helicobacter+pylori+infection+and+its+eradication+on+gastric+regenerating+atypia+in+22+133+subjects&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Ji+Hyung+Nam&rft.au=Su+Youn+Nam&rft.au=Park%2C+Bum+Joon&rft.au=Ryu%2C+Kum+Hei&rft.date=2020-09-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=35&rft.issue=9&rft.spage=1532&rft.epage=1539&rft_id=info:doi/10.1111%2Fjgh.15016&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon